The four key pathways linking inflammation and cancer progression are nuclear factor kappa B (NF-κB), Janus kinase (JAK)-signal transducer and activator of transcription (STAT), mitogen activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K)/Akt (protein kinase B) [26]. Here, AKT1 is linked to cancer.